Halozyme Therapeutics, Inc.

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

3,222,507

Value ($000)

216,875

Weight

0.1%

2019 Q4 - 2025 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	216,875	0.1%	3,222,507	12/31/2025
2025 Q3	11/13/2025	241,337	0.2%	3,290,665	9/30/2025
2025 Q2	8/13/2025	132,192	0.1%	2,541,181	6/30/2025
2025 Q1	5/14/2025	71,181	0.1%	1,115,507	3/31/2025
2024 Q4	2/12/2025	47,470	0.0%	992,887	12/31/2024
2024 Q3	11/14/2024	23,549	0.0%	411,412	9/30/2024
2024 Q2	8/14/2024	5,380	0.0%	102,749	6/30/2024
2024 Q1	5/15/2024	281	0.0%	6,899	3/31/2024
2023 Q3	11/14/2023	3,866	0.0%	101,211	9/30/2023
2022 Q3	11/14/2022	10,740	0.0%	271,615	9/30/2022
2022 Q2	8/15/2022	7,005	0.0%	159,201	6/30/2022
2021 Q3	11/12/2021	16,929	0.0%	416,140	9/30/2021
2020 Q3	11/12/2020	1,666	0.0%	63,400	9/30/2020
2020 Q2	8/12/2020	335	0.0%	12,484	6/30/2020
2020 Q1	5/15/2020	1,873	0.0%	104,097	3/31/2020
2019 Q4	2/13/2020	6,848	0.0%	386,241	12/31/2019